6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine

C93H171N19O3 — CID 159055819

IUPAC6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine
SMILESCCCCN(c1nc(OCCC(COc2nc(N(CCCC)C3CC(C)(C)NC(C)(C)C3)nc(N(CCCC)C3CC(C)(C)NC(C)(C)C3)n2)Oc2nc(N(CCCC)C3CC(C)(C)CC(C)(C)C3)nc(N(CCCC)C3CC(C)(C)CC(C)(C)C3)n2)nc(N(CCCC)C2CC(C)(C)NC(C)(C)C2)n1)C1CC(C)(C)NC(C)(C)C1
InChIInChI=1S/C93H171N19O3/c1-31-37-44-107(66-51-82(7,8)64-83(9,10)52-66)77-96-78(108(45-38-32-2)67-53-84(11,12)65-85(13,14)54-67)102-81(101-77)115-72(63-114-80-99-75(111(48-41-35-5)70-59-90(23,24)105-91(25,26)60-70)95-76(100-80)112(49-42-36-6)71-61-92(27,28)106-93(29,30)62-71)43-50-113-79-97-73(109(46-39-33-3)68-55-86(15,16)103-87(17,18)56-68)94-74(98-79)110(47-40-34-4)69-57-88(19,20)104-89(21,22)58-69/h66-72,103-106H,31-65H2,1-30H3
InChIKeyCDWQQSTYSQRLRQ-UHFFFAOYSA-N
MW1603.52 g/mol
LogP19.62
Rot. Bonds39

About 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine

6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine (PubChem CID 159055819) has the molecular formula C93H171N19O3 and a molecular weight of 1603.52 g/mol. Its IUPAC name is 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine.

Molecular Properties

Compound Name6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine
PubChem CID159055819
Molecular FormulaC93H171N19O3
Molecular Weight1603.52 g/mol
Exact Mass1602.38
IUPAC Name6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine
SMILESCCCCN(c1nc(OCCC(COc2nc(N(CCCC)C3CC(C)(C)NC(C)(C)C3)nc(N(CCCC)C3CC(C)(C)NC(C)(C)C3)n2)Oc2nc(N(CCCC)C3CC(C)(C)CC(C)(C)C3)nc(N(CCCC)C3CC(C)(C)CC(C)(C)C3)n2)nc(N(CCCC)C2CC(C)(C)NC(C)(C)C2)n1)C1CC(C)(C)NC(C)(C)C1
InChIInChI=1S/C93H171N19O3/c1-31-37-44-107(66-51-82(7,8)64-83(9,10)52-66)77-96-78(108(45-38-32-2)67-53-84(11,12)65-85(13,14)54-67)102-81(101-77)115-72(63-114-80-99-75(111(48-41-35-5)70-59-90(23,24)105-91(25,26)60-70)95-76(100-80)112(49-42-36-6)71-61-92(27,28)106-93(29,30)62-71)43-50-113-79-97-73(109(46-39-33-3)68-55-86(15,16)103-87(17,18)56-68)94-74(98-79)110(47-40-34-4)69-57-88(19,20)104-89(21,22)58-69/h66-72,103-106H,31-65H2,1-30H3
InChIKeyCDWQQSTYSQRLRQ-UHFFFAOYSA-N
XLogP19.62
TPSA211.26 Ų
H-Bond Donors4
H-Bond Acceptors22
Rotatable Bonds39
Heavy Atoms115
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001603.52
LogP ≤ 519.62
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1022

Analyze 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine?
The IUPAC name of 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine (CID 159055819) is 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine.
What is the SMILES notation for 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine?
The canonical SMILES for 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine is CCCCN(c1nc(OCCC(COc2nc(N(CCCC)C3CC(C)(C)NC(C)(C)C3)nc(N(CCCC)C3CC(C)(C)NC(C)(C)C3)n2)Oc2nc(N(CCCC)C3CC(C)(C)CC(C)(C)C3)nc(N(CCCC)C3CC(C)(C)CC(C)(C)C3)n2)nc(N(CCCC)C2CC(C)(C)NC(C)(C)C2)n1)C1CC(C)(C)NC(C)(C)C1.
What is the InChIKey of 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine?
The InChIKey is CDWQQSTYSQRLRQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C93H171N19O3/c1-31-37-44-107(66-51-82(7,8)64-83(9,10)52-66)77-96-78(108(45-38-32-2)67-53-84(11,12)65-85(13,14)54-67)102-81(101-77)115-72(63-114-80-99-75(111(48-41-35-5)70-59-90(23,24)105-91(25,26)60-70)95-76(100-80)112(49-42-36-6)71-61-92(27,28)106-93(29,30)62-71)43-50-113-79-97-73(109(46-39-33-3)68-55-86(15,16)103-87(17,18)56-68)94-74(98-79)110(47-40-34-4)69-57-88(19,20)104-89(21,22)58-69/h66-72,103-106H,31-65H2,1-30H3.
What are the key properties of 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine?
6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine has a molecular weight of 1603.52 g/mol, XLogP of 19.62, 39 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[3-[[4,6-bis[butyl-(3,3,5,5-tetramethylcyclohexyl)amino]-1,3,5-triazin-2-yl]oxy]-4-[[4,6-bis[butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]-1,3,5-triazin-2-yl]oxy]butoxy]-2-N,4-N-dibutyl-2-N,4-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine is sourced from PubChem (CID 159055819), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).